Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Benzac Acne Treatment Stages Dramatic Launch In Instagram Video Series

This article was originally published in The Tan Sheet

Executive Summary

Galderma reaches out to teens on Instagram to promote Benzac Acne Solutions. The firms say the series is the first-of-its kind and features 22 short episodes that will run for three weeks, connecting teens with the brand through the common experience of acne.

You may also be interested in...



FTC Will Ask Congress To Sharpen Monetary Relief Authority Dulled By Supreme Court Ruling

Justice Breyer suggests FTC ask Congress to strengthen its enforcement rules. It is “free to ask Congress to grant it further remedial authority,” according to court opinion stating a rule the FTC has wielded for forty years to impose financial penalties doesn’t grant it authority to obtain equitable monetary relief.

Direct Seller’s Advertising Mixing Boosting Health With Building Wealth Made Known To FTC

Bulavita didn’t respond to Direct Selling Regulatory Council’s inquiry on claims its supplements could boost the immune system against COVID-19. In an assessment of the claims, the industry self-regulation group it would refer its questions to the FTC.

P&G Begins US Price Increases In Baby And Feminine Care, Could Expand To Health, Beauty

P&G plans up to double-digit price increases in US baby care, feminine care and adult incontinence and will analyze raw material costs and foreign exchange impacts in its other product categories for other pricing changes.

Topics

UsernamePublicRestriction

Register

PS107658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel